Details

Generalized Anxiety Disorder Across the Lifespan

An Integrative Approach

von: Michael E. Portman
96,29 €
Verlag:	Springer
Format:	PDF
Veröffentl.:	05.03.2009
ISBN/EAN:	9780387892436
Sprache:	englisch
Anzahl Seiten:	182

In den Warenkorb

Als Gutschein

Dieses eBook enthält ein Wasserzeichen.

Beschreibungen

Nature of Generalized Anxiety Disorder.- Assessment and Diagnosis.- Conceptual Models.- Psychosocial Treatments for Adults with Generalized Anxiety Disorder.- Pharmacotherapy for Generalized Anxiety Disorder.- Special Populations.- Enigmas and Paradoxes.- Future Directions and Recommendations.

Autorenportrait

Michael E. Portman, DPhil, LISW-S, has worked as a full-time staff clinical social worker at the Cleveland Veteran's Administration. He provided individual and group therapy to a patient population consisting of veterans with severe mental disorders. He was also an adjunct faculty member at Case Western Reserve University, Mandel School of Applied Social Sciences, and maintained a private practice specializing in the treatment of mood and anxiety disorders, especially Generalized Anxiety Disorder, for ten years. In addition to his clinical experience, Dr. Portman received a Doctorate of Philosophy in Social Work from The University of South Africa, a MSW from The Ohio State University, and a M.A. in Psychology from The New School for Social Research. He is currently setting up a private practice in Israel, where he now lives with his family. Dr. Portman was also recently featured in an article in The Jerusalem Post. Check out an excerpt below:"A leading US expert on CBT and its use for treating phobias, obsessions and general anxiety disorder (GAD) came on aliya from Ohio in May and settled with his wife Riva and children in Jerusalem. Dr. Michael Portman (meport18@gmail.com), a psychologist and social worker whose textbook on GAD (Generalized Anxiety Disorder Across the Lifespan) was published not long ago by Springer, and his article on the subject was printed in Psychiatric Annals. Both were widely praised by mentalhealth professionals. The family thus joins his father, a retired obstetrician/gynecologist, and his mother, an artist, who moved to the capital 12 years ago. " (article by Judy Siegel-Itzkovich, November 20, 2011)To read the entire article please copy and paste this URL address in your browser:http://www.jpost.com/Health/Article.aspx?id=246216

Back cover copy

Generalized anxiety disorder is a chronic, disabling, often lifelong condition affecting millions worldwide. Yet, despite its prevalence, GAD is frequently marginalized, misdiagnosed, and undertreated. Generalized Anxiety Disorder Across the Lifespan provides a practical knowledge base for GAD, identifying the symptoms that set it apart both from "normal, everyday" anxiety and from other anxiety-based pathologies, and thoroughly reviewing the range of established and cutting-edge treatments. The author’s developmental approach sheds some light on longstanding clinical mysteries surrounding the disorder, among them the interplay of somatic and psychological symptoms and the changes in symptoms as patients age. Accessible to the novice or the veteran reader, the book:

<UL>

<LI>Grounds readers in the basics of GAD</LI>


<LI>Offers extensive discussion of the current psychosocial treatments for GAD</LI>


<LI>Examines the state of the art in pharmacological therapies with explanations of the genetic and neurobiological correlates</LI>


<LI>Explores special issues, cultural considerations, treatment resistant patients, and prevention</LI>


<LI>Includes guidelines for treatment of GAD in children, adolescents, adults, and older adults</LI>


<LI>Features ready-to-use assessment tools for patients across the lifespan</LI>
</UL>

Generalized Anxiety Disorder Across the Lifespan is a rich resource for clinicians, researchers, and graduate students looking to improve patients’ quality of life—and the quality of their care. It is both a guide to current best practice and a springboard for future innovations. "In this clearly written volume, Michael Portman has succeeded in effectively applying his clinical experience and outstanding grasp of the conceptual and empirical literature to the understanding and treatment of Generalized Anxiety Disorder (GAD).He correctly emphasizes the need to tailor a pure or integrated treatment to the individual case based on the empirical evidence available and the clinician’s judgment. One comes away from reading this splendid book exceedingly well informed about the best that the field has to offer those suffering from GAD." -Stanley B. Messer, PhD, Professor II and Dean, Graduate School of Applied and Professional Psychology, Rutgers University "In this book, Portman brings us up-to-date with the research that has firmly established GAD as a separate disorder. In an extensive review of the literature, he discusses various concepts of GAD, the attempts of defining and measuring the disorder and of quantifying its severity. Separate chapters describe the development and effectiveness of psychosocial and psychopharmacologic treatments in the general as well as in special GAD populations. Finally, this new publication discusses future research necessary to fully understand the disorder.  The strength of the book is Portman’s ability to present, objectively, diverse studies and views which enable the reader to form an independent opinion of the present state of GAD and the need for ongoing research. This volume is a valuable contribution and will be necessary reading for anybody interested in GAD." -Rudolf Hoehn-Saric, MD, Professor Emeritus of Psychiatry, Johns Hopkins University, School of Medicine

Sonderbeitrag

Addresses GAD from a clinical perspective by discussing the multiple ways in which the disorder presents itself in doctor’s offices, clinics and private practices Written from a multimodal orientation, treating GAD as a heterogeneous malady and based on the premise that “one-size does not fit all” Discusses a broad range of approaches including older well established models such as CBT to newer models still going through clinical trials such as ERT and Acceptance-Based Therapy Includes supplementary material: sn.pub/extras